OpenVSafe by OpenVAERS
Search V-safe

3CV-33683-01216

3 vaccinations 1 coded response 4 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
05-11
ZIP prefix
946 / CA
Registered
2022-06-21
Relationship
Child or adolescent in my care
Guardian
8BP-21997-12625
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-11-05
    Dose 1 — Pfizer-BioNTech
  2. 2021-11-26
    Dose 2 — Pfizer-BioNTech
  3. 2022-05-30
    Dose 3 — Pfizer-BioNTech
  4. 2022-06-21
    Registered in v-safe
  5. 2022-06-21
    Health check-in — day 21, dose 3, dependent
    Feeling: Good
    Adult check-in
  6. 2022-06-27
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  7. 2022-07-13
    Survey response — day 42, dose 3, dependent
    MedDRA: Headache, Nasal congestion, Oropharyngeal pain, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Headache Sore throat Runny and stuffy nose
    MedDRA releases: 2024-11 · check-in free text available
  8. 2023-05-30

Vaccinations

DoseDateManufacturerCo-administered
12021-11-05Pfizer-BioNTech No
22021-11-26Pfizer-BioNTech No
32022-05-30Pfizer-BioNTech No

Free text

Release 12 — day 42, dose 3, dependent

2022-07-13

Symptoms: Headache Sore throat Runny and stuffy nose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache · · ✓
SDNasal congestion · · ✓
SDOropharyngeal pain · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release